Domperidon-Mepha oro 10 mg, Schmelztabletten

7680656460019 CH-65646 Schmelztabletten
Domperidon-Mepha oro 10 mg, Schmelztabletten
Domperidon-Mepha oro 10 mg, Schmelztabletten
Domperidon-Mepha oro 10 mg, Schmelztabletten
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Tablette(n)
Galenic form
Schmelztabletten
Galenic group
Lutschtabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/10/2021
Patient information leaflet
Français
29/10/2021
Patient information leaflet
Italien
29/10/2021
Summary of Product Characteristics
Allemand
28/10/2021
Summary of Product Characteristics
Français
28/10/2021
Summary of Product Characteristics
Italien
28/10/2021

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AIMDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
60.0 UG Substance HBESI

Reimbursement information

Public price
CHF 11.90
Specialties list
Yes
Generic
Yes
SL addition date: 01/11/2015

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
65646
Drug name
Domperidon-Mepha oro, Schmelztabletten
Galenic form
SCHM
ATC Code
A03FA03
Authorization status
Z
Dispensing category
B
First authorization
03/06/2015
Authorization expiration date
31/12/9999
IT Number
04.06.0.
Domain
Human medicine
Field of application
Übelkeit und Erbrechen

Package details

Description (FR)
DOMPERIDON Mepha oro cpr orodisp 10 mg 30 pce
Description (DE)
DOMPERIDON Mepha oro Schmelztabl 10 mg 30 Stk
Market launch
03/06/2015
Narcotic (BTM)
No

Original drug

Motilium, Filmtabletten
GTIN: 7680419030152
CHF 12.20
View original

Other package sizes (1)

DOMPERIDON Mepha oro cpr orodisp 10 mg 100 pce
100 TABL
GTIN: 7680656460026
View